when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

LILLY · news · pharmadog

← back to LILLY

News mentioning LILLY

793 stories

Sep 24, 26Growth mode: 3 biotechs that are staffing up after series B raisesbiospace

Sep 24, 26Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCarefiercebiotech

Sep 24, 26Recon: Adcomm backs Grail’s cancer test; Lilly, China’s InnoCare sign $3.35B dealraps

Sep 23, 26‘It’s certainly not easy’: How are Boston biotechs coping with a shallower pool of seed funding?fiercebiotech

Sep 23, 26STAT+: Flagship gets a Pentagon contractstat

Sep 23, 26The latest in the legal saga for youth gender-affirming care in the U.S.stat

Sep 23, 26Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitzbiospace

Sep 23, 26STAT+: A private equity-owned hospital chain is becoming a nonprofit. Is it just a bailout for investors?stat

Sep 23, 26STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatmentsstat

Sep 23, 269 companies hiring in Pennsylvania nowbiospace

Sep 23, 26Pharmas face off for manufacturing talent amidst reshoring effortsbiospace

Sep 22, 26STAT+: Did the Trump administration just cut Novo a huge financial win?stat

Sep 22, 26Viking shares surge on updated obesity drug databiopharma dive

Sep 22, 26Viking achieves 'maintenance trifecta' as GLP-1/GIP dual agonist exceeds expectationsbiospace

Sep 22, 26Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030biospace

Sep 22, 26Lilly presents early data supporting GLP-1/GIP candidate's potential in depression, alcohol use disorderbiospace

Sep 22, 26STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge programstat

Sep 22, 262026 IPO blitz continues with 4 new biotech filingsbiospace

Sep 22, 26An orexin drug’s ‘proof-of-concept’ in ADHD; Cue’s ‘unwarranted’ share slidebiopharma dive

Sep 22, 26Novo’s workforce reduction climbs to 13,000 to fuel R&D workbiospace

Sep 22, 26Roche’s Carmot asset normalizes blood sugar, cuts weight in Phase 2 diabetes trialbiospace

Sep 22, 26STAT+: Ohio governor’s race is a battle over Covid, health costs, and trust in sciencestat

Sep 22, 26Deep Dive: How AI is now essential in biopharmabiospace

Sep 22, 26Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopesfiercebiotech

Sep 22, 26Iambic maintains momentum from string of Big Pharma partnerships by aiming for IPOfiercebiotech

Sep 21, 26STAT+: What a vote on Grail’s cancer detection test could mean for the company, patients, and regulatorsstat

Sep 21, 26Novo talks up drug launches in effort to win back investorsbiopharma dive

Sep 21, 26Pfizer, Lilly 'most favored nation' deals to give US share of raised foreign pricesendpoints

Sep 21, 26Novo offers low-dose CagriSema data as approval decision loomsendpoints

Sep 21, 26STAT+: Lilly’s breast cancer combo wins approvalstat

← prevpage 8 of 27next →